Skip to content
Longterm Wiki
Back

BMFTR - Coalition for Epidemic Preparedness Innovations

web

Author

Redaktion: BMFTR LS5 Internetredaktion

This resource is tangentially relevant to AI safety via its model of international coordination for catastrophic risk mitigation; more directly relevant to biosecurity and pandemic preparedness governance discussions.

Metadata

Importance: 18/100organizational reportreference

Summary

This page from the German Federal Ministry for Research provides an overview of CEPI, an international alliance founded in 2017 to finance and coordinate the development of vaccines against emerging infectious diseases. CEPI aims to accelerate vaccine development to counter epidemic threats before they become pandemics. The page outlines Germany's involvement and funding contributions to this global health security initiative.

Key Points

  • CEPI was founded in 2017 at Davos as a public-private partnership to develop vaccines against epidemic-prone pathogens
  • The coalition focuses on proactive vaccine R&D for diseases with pandemic potential, reducing response time during outbreaks
  • Germany, through BMFTR, is a contributing partner supporting CEPI's mission of global epidemic preparedness
  • CEPI represents a model of international coordination for biosecurity and pandemic risk mitigation
  • The initiative addresses gaps in vaccine development for diseases that lack commercial incentives for private sector investment

Cited by 1 page

Cached Content Preview

HTTP 200Fetched Mar 15, 20264 KB
Coalition for Epidemic Preparedness Innovations (CEPI) - Gesundheitsforschung BMFTR 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 




 
 
 
 

 
 
 
 
 

 








 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 Skip to content (Enter)
 
 

 
 
 Skip to navigation (Enter)
 
 

 
 
 Skip to search (Enter)
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 International Cooperation 
 
 Collaborations in Global Health 

 
 
 
 
 
 
 
 
 Coalition for Epidemic Preparedness Innovations (CEPI)


 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CEPI is an international initiative to finance and coordinate the development of new vaccines against pathogens with high pandemic potential. 

 By enabling the development of suitable vaccines against pathogens, which may cause epidemics, CEPI aims to stop epidemics before they turn into large-scale health emergencies and pandemics, respectively. In order to avoid future humanitarian disasters caused by epidemics and pandemics, vaccines should be readily available where and when needed most.

 International efforts to fight the global threat of epidemics 

 Since some diseases offer little economic incentives for pharmaceutical companies to take on the high development costs for vaccines, public funding by the international community is needed.

 CEPI brings together governments, industry, academia, philanthropy, intergovernmental institutions, such as the World Health Organization, and civil society. The initiative focuses on diseases that the World Health Organization (WHO) has identified as possible originators for future pandemics. Since its foundation in 2017, CEPI has supported the development of 8 authorized COVID-19 vaccines, as well as the first ever authorized vaccine against Chikungunya. In addition, CEPI aims to advance the 100 Days Mission, i.e. the development of a new vaccine within 100 days, for instance by the development of platform technologies and prototype vaccines.

 CEPI funding as one component of the German engagement in Global Health 

 Germany is founding member and one of the most important donors of CEPI: So far, Germany has provided 150 Mio. EUR for CEPI’s core portfolio and 430 Mio. EUR for its COVID-19 portfolio via the international campaign „Access to COVID-19 Tools Accelerator“ (ACT-A). Until 2026, Germany intends to provide additional 40 Mio. EUR for CEPI’s core portfolio.

 

 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Further Information


 
 
 
 

 
 
 

 

 

 
 

 

 
 CEPI: New vaccines for a safer world 

 Twitter: @CEPIvaccines 

 #OutsmartEpidemics

 

 
 

 
 
 

 

 

 
 

 With the support of CEPI, the BMBF contributes to the EDCTP2 programme, supported by the European Union. EDCTP 


 
 
 
 
 
 
 
 
 Press Release


 
 
 
 CEPI Awards Contract Worth up to $36 million to Pro

... (truncated, 4 KB total)
Resource ID: 0145d61ec7c3e46e | Stable ID: YjM2ZTdkNz